# Weiguang Biological
Latest news and articles about Weiguang Biological
Total: 2 articles found

Health
Closing the Treatment Gap: Weiguang Biological Advances Hemophilia B Candidate in China
Weiguang Biological has received regulatory approval to begin clinical trials for Human Coagulation Factor IX, targeting Hemophilia B. This development marks a significant step in China's domestic rare disease treatment capabilities, though the company warns of the long-term risks inherent in drug development.
NeTe2026年6月1日 09:08
#Weiguang Biological#Hemophilia B#NMPA

Health
Weiguang Bio Advances Patient-Centric Care with Subcutaneous Immunoglobulin Trial Approval
Weiguang Biological has received NMPA approval to begin clinical trials for a subcutaneous human immunoglobulin injection. The therapy targets primary immunodeficiency diseases and represents a shift toward home-based, patient-friendly administration in the Chinese plasma market.
NeTe2026年3月24日 10:07
#Weiguang Biological#NMPA#Immunoglobulin